Results
|
2141.
|
Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma. [electronic resource] by
- Chilà, Rosaria
- Basana, Alessandra
- Lupi, Monica
- Guffanti, Federica
- Gaudio, Eugenio
- Rinaldi, Andrea
- Cascione, Luciano
- Restelli, Valentina
- Tarantelli, Chiara
- Bertoni, Francesco
- Damia, Giovanna
- Carrassa, Laura
Producer: 20160328
In:
Oncotarget vol. 6
Availability: No items available.
|
|
2142.
|
|
|
2143.
|
|
|
2144.
|
Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. [electronic resource] by
- Morgan, Meredith A
- Parsels, Leslie A
- Zhao, Lili
- Parsels, Joshua D
- Davis, Mary A
- Hassan, Maria C
- Arumugarajah, Sankari
- Hylander-Gans, Linda
- Morosini, Deborah
- Simeone, Diane M
- Canman, Christine E
- Normolle, Daniel P
- Zabludoff, Sonya D
- Maybaum, Jonathan
- Lawrence, Theodore S
Producer: 20100722
In:
Cancer research vol. 70
Availability: No items available.
|
|
2145.
|
|
|
2146.
|
The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR. [electronic resource] by
- Zhou, Liang
- Chen, Shuang
- Zhang, Yu
- Kmieciak, Maciej
- Leng, Yun
- Li, Lihong
- Lin, Hui
- Rizzo, Kathryn A
- Dumur, Catherine I
- Ferreira-Gonzalez, Andrea
- Rahmani, Mohamed
- Povirk, Lawrence
- Chalasani, Sri
- Berger, Allison J
- Dai, Yun
- Grant, Steven
Producer: 20170619
In:
Blood vol. 127
Availability: No items available.
|
|
2147.
|
|
|
2148.
|
|
|
2149.
|
Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer. [electronic resource] by
- Bennett, Christina N
- Tomlinson, Christine C
- Michalowski, Aleksandra M
- Chu, Isabel M
- Luger, Dror
- Mittereder, Lara R
- Aprelikova, Olga
- Shou, James
- Piwinica-Worms, Helen
- Caplen, Natasha J
- Hollingshead, Melinda G
- Green, Jeffrey E
Producer: 20150624
In:
Breast cancer research : BCR vol. 14
Availability: No items available.
|
|
2150.
|
|
|
2151.
|
|
|
2152.
|
|
|
2153.
|
|
|
2154.
|
|
|
2155.
|
|
|
2156.
|
|
|
2157.
|
Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors. [electronic resource] by
- Zhang, Ming
- Singh, Ratnakar
- Peng, Shaohua
- Mazumdar, Tuhina
- Sambandam, Vaishnavi
- Shen, Li
- Tong, Pan
- Li, Lerong
- Kalu, Nene N
- Pickering, Curtis R
- Frederick, Mitchell
- Myers, Jeffrey N
- Wang, Jing
- Johnson, Faye M
Producer: 20170807
In:
Cancer letters vol. 392
Availability: No items available.
|